We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

160 hedge funds and large institutions have $1.82B invested in Mirum Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more funds holding in top 10

Funds holding in top 10: 4 → 9 (+5)

49% more call options, than puts

Call options by funds: $3.64M | Put options by funds: $2.44M

36% more capital invested

Capital invested by funds: $1.34B → $1.82B (+$486M)

33% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 49

1% less ownership

Funds ownership: 114.24% → 113.24% (-1%)

7% less funds holding

Funds holding: 172 → 160 (-12)

31% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 36

Holders
160
Holders Change
-12
Holders Change %
-6.98%
% of All Funds
2.31%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.13%
New
25
Increased
65
Reduced
49
Closed
36
Calls
$3.64M
Puts
$2.44M
Net Calls
+$1.2M
Net Calls Change
+$1.34M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$58.2M
2
BlackRock
BlackRock
New York
+$20.6M
3
CS
Candriam SCA
Luxembourg
+$13.3M
4
MB
MPM BioImpact
Massachusetts
+$12.9M
5
ClearBridge Investments
ClearBridge Investments
New York
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$34.8M
2
CCM
Cadian Capital Management
New York
-$27.7M
3
APM
Avidity Partners Management
Texas
-$10.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.4M
5
CC
Checkpoint Capital
California
-$9.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
26
MPM BioImpact
Massachusetts
$16.8M +$12.9M +492,569 New
Axa
27
Axa
France
$14.6M -$4.4M -167,794 -28%
N
28
Nuveen
North Carolina
$13.9M +$2.52M +95,934 +31%
Bank of America
29
Bank of America
North Carolina
$11.4M +$511K +19,488 +6%
PM
30
Prosight Management
Texas
$10.8M -$3.94M -150,200 -32%
Charles Schwab
31
Charles Schwab
California
$10.6M +$1.03M +39,358 +14%
Invesco
32
Invesco
Georgia
$9.71M +$6.42M +245,024 +628%
Northern Trust
33
Northern Trust
Illinois
$9.48M -$97.3K -3,713 -1%
Millennium Management
34
Millennium Management
New York
$9.08M -$7.19M -274,223 -51%
EAM
35
Erste Asset Management
Austria
$8.86M – – –
Deutsche Bank
36
Deutsche Bank
Germany
$8.52M +$128K +4,900 +2%
PCM
37
Penn Capital Management
Pennsylvania
$8.26M -$119K -4,545 -2%
Barclays
38
Barclays
United Kingdom
$8.04M -$1.04M -39,772 -14%
RHJA
39
Rice Hall James & Associates
California
$7.85M +$389K +14,843 +7%
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$7.61M – – –
SAM
41
Silvercrest Asset Management
New York
$7.54M +$1.51M +57,673 +35%
Citigroup
42
Citigroup
New York
$7.27M -$4.16M -158,547 -43%
WP
43
Woodline Partners
California
$6.97M -$775K -29,547 -13%
BBA
44
Baker Bros. Advisors
New York
$6.51M – – –
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$6.5M -$172K -6,554 -3%
AAP
46
Ardsley Advisory Partners
Connecticut
$6.15M -$1.7M -65,000 -27%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$6.15M -$448K -17,100 -9%
Two Sigma Investments
48
Two Sigma Investments
New York
$5.59M +$215K +8,187 +5%
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$5.47M – – –
AAA
50
Affinity Asset Advisors
New York
$5.3M -$131K -5,000 -3%
1
2
3 4 5

MIRM Hedge Fund Activity: Q2 2024 in Review

160 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2024, worth a combined $1.82B — up 36% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of MIRM and 25 opened new positions — a net loss of 11 holders — while 49 trimmed existing stakes and 65 added.

The largest buyer was Janus Henderson Group, adding an estimated $58.2M. The largest seller was State Street, cutting an estimated $34.8M.

  • 160 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2024, down from 172 in Q1 2024.
  • Funds reported $1.82B of Mirum Pharmaceuticals stock for Q2 2024, up 36% quarter-over-quarter.
  • 25 funds opened new Mirum Pharmaceuticals positions in Q2 2024 and 36 closed out, a net change of -11 holders.
  • The largest Mirum Pharmaceuticals buyer in Q2 2024 was Janus Henderson Group, an estimated $58.2M added.
  • The largest Mirum Pharmaceuticals seller in Q2 2024 was State Street, an estimated $34.8M sold.

Based on aggregated 13F filings for Q2 2024.